Sandbox:Mitra3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | ! | | | | |!| | |}} | {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | ! | | | | |!| | |}} | ||
{{familytree |boxstyle=text-align: left; | | | | C01 | | | | | C02 | | | | | C03| | | C05| | C06| | | | | {{familytree |boxstyle=text-align: left; | | | | C01 | | | | | C02 | | | | | C03| | | C05| | C06| | | | | ||
C01=• Thrmobolysis<br>• Percutaneous coronary intervention< | C01=• Thrmobolysis<br>• Percutaneous coronary intervention<be> | ||
C02 | |C02= • Avoidance of preload reducing agents, such as:<br> | ||
*Nitrates | *Nitrates | ||
*Diuretics | *Diuretics | ||
*Morphin | *Morphin | ||
|C03=• | |C03=• Systemic or pulmonary vasodilators:<br> *Inhaled nitric oxide<br> | ||
|C04=• In patients with bradyarrhthmias: | |||
Atropine | |||
Pacemaker | |||
|C05=Inotropic support | |||
|C06= May be needed in patients with cardiogenic shock secondary to RVMI}} | |||
{{familytree | | | | | | | | | | | |!| | | |!| }} | {{familytree | | | | | | | | | | | |!| | | |!| }} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 17:32, 3 August 2020
| Therapuetic Considerations in RVMI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reperfusion | Maintenance of RV preload | Decreased RV afterload | Restoring Rate/Rhythm and AV synchrony | Inotropic support | Mechanical Circulatory Support | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| {{{ ! }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| • Thrmobolysis • Percutaneous coronary intervention<be> | • Avoidance of preload reducing agents, such as:
| • Systemic or pulmonary vasodilators: *Inhaled nitric oxide | Inotropic support | May be needed in patients with cardiogenic shock secondary to RVMI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||